Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CXC motif chemokine ligand 12 (CXCL12), also known as stromal cell-derived factor 1 (SDF-1), is a small, secreted cytokine belonging to the CXC chemokine family. It plays critical roles in cell signaling, development, immune response, and cancer biology by binding to receptors such as CXCR4 and ACKR3. The CXCL12–CXCR4 axis is an important target for anticancer drug discovery due to its involvement in tumor growth, angiogenesis, metastasis, and shaping the tumor microenvironment.
Binding to CXCR4 and ACKR3 receptors, triggering downstream signaling pathways that regulate chemotaxis, cell survival, proliferation, migration, and gene expression. Inhibitors block the interaction of CXCL12 with its receptors.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CXC motif chemokine ligand 12 (CXCL12).